Sanofi Reaffirms Commitment to AI Drug Discovery with $1.2B Insilico Pact

Sanofi has once again entered into a partnership with an artificial intelligence-based drug development firm - this time with Insilico Medicine – in a deal that could be worth as much as $1.2 billion.